{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:12:24Z","timestamp":1774368744943,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,20]]},"DOI":"10.7759\/cureus.29383","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T06:15:33Z","timestamp":1663740933000},"source":"Crossref","is-referenced-by-count":3,"title":["Current Status of Adverse Event Profile of Cyclosporine in Kidney, Stem Cell, and Heart Transplantations Using the Japanese Pharmacovigilance Database"],"prefix":"10.7759","author":[{"given":"Iku","family":"Niinomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kambara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayako","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Hosohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00683.x","article-title":"Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients","volume":"30","author":"Lukas JC","year":"2005","unstructured":"Lukas JC, Su\u00e1rez AM, Valverde MP, et al.. Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients. J Clin Pharm Ther. 2005, 30:549-57. 10.1111\/j.1365-2710.2005.00683.x","journal-title":"J Clin Pharm Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1526924820913514","article-title":"Immunosuppressant use and gout in the prevalent solid organ transplantation population","volume":"30","author":"Brigham MD","year":"2020","unstructured":"Brigham MD, Milgroom A, Lenco MO, et al.. Immunosuppressant use and gout in the prevalent solid organ transplantation population. Prog Transplant. 2020, 30:103-10. 10.1177\/1526924820913514","journal-title":"Prog Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.01.057","article-title":"Cyclosporine nephrotoxicity","volume":"36","author":"Griny\u00f3 JM","year":"2004","unstructured":"Griny\u00f3 JM, Cruzado JM. Cyclosporine nephrotoxicity. Transplant Proc. 2004, 36:240S-2S. 10.1016\/j.transproceed.2004.01.057","journal-title":"Transplant Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s001470050708","article-title":"Neurotoxicity of calcineurin inhibitors: Impact and clinical management","volume":"13","author":"Bechstein WO","year":"2000","unstructured":"Bechstein WO. Neurotoxicity of calcineurin inhibitors: Impact and clinical management. Transpl Int. 2000, 13:313-26. 10.1007\/s001470050708","journal-title":"Transpl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13693","article-title":"Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase","volume":"84","author":"Mah\u00e9 J","year":"2018","unstructured":"Mah\u00e9 J, de Campaigno EP, Chen\u00e9 AL, Montastruc JL, Despas F, Jolliet P. Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase. Br J Clin Pharmacol. 2018, 84:2373-83. 10.1111\/bcp.13693","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045948","article-title":"Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008-2017","volume":"11","author":"Lee Y","year":"2021","unstructured":"Lee Y, Choi A, Noh Y, Jeon HL, Choe SA, Shin JY. Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008-2017. BMJ Open. 2021, 11:e045948. 10.1136\/bmjopen-2020-045948","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12748","article-title":"Surveillance of drugs that most frequently induce acute kidney injury: a pharmacovigilance approach","volume":"44","author":"Hosohata K","year":"2019","unstructured":"Hosohata K, Inada A, Oyama S, Furushima D, Yamada H, Iwanaga K. Surveillance of drugs that most frequently induce acute kidney injury: a pharmacovigilance approach. J Clin Pharm Ther. 2019, 44:49-53. 10.1111\/jcpt.12748","journal-title":"J Clin Pharm Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13001","article-title":"Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: subgroup analysis based on a Japanese spontaneous database","volume":"44","author":"Inada A","year":"2019","unstructured":"Inada A, Oyama S, Niinomi I, Wakabayashi T, Iwanaga K, Hosohata K. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: subgroup analysis based on a Japanese spontaneous database. J Clin Pharm Ther. 2019, 44:775-9. 10.1111\/jcpt.13001","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2020.0604","article-title":"Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study","volume":"75","author":"Kambara H","year":"2020","unstructured":"Kambara H, Hosohata K, Nakatsuji T, et al.. Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study. Pharmazie. 2020, 75:527-30. 10.1691\/ph.2020.0604","journal-title":"Pharmazie"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00788-3","article-title":"Comparison of safety profiles of new oral anticoagulants with warfarin using the japanese spontaneous reporting database","volume":"39","author":"Hosohata K","year":"2019","unstructured":"Hosohata K, Oyama S, Niinomi I, Wakabayashi T, Inada A, Iwanaga K. Comparison of safety profiles of new oral anticoagulants with warfarin using the japanese spontaneous reporting database. Clin Drug Investig. 2019, 39:665-70. 10.1007\/s40261-019-00788-3","journal-title":"Clin Drug Investig"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1091581819870717","article-title":"Pharmacovigilance assessment of drug-induced acute pancreatitis using a spontaneous reporting database","volume":"38","author":"Niinomi I","year":"2019","unstructured":"Niinomi I, Hosohata K, Oyama S, Inada A, Wakabayashi T, Iwanaga K. Pharmacovigilance assessment of drug-induced acute pancreatitis using a spontaneous reporting database. Int J Toxicol. 2019, 38:487-92. 10.1177\/1091581819870717","journal-title":"Int J Toxicol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3529","article-title":"Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases","volume":"23","author":"Maignen F","year":"2014","unstructured":"Maignen F, Hauben M, Hung E, Van Holle L, Dogne JM. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases. Pharmacoepidemiol Drug Saf. 2014, 23:195-207. 10.1002\/pds.3529","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-021-01993-y","article-title":"Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1+ dendritic cells, and epithelium-free areas containing Foxp3+ thymic regulatory T cells","volume":"156","author":"Sawanobori Y","year":"2021","unstructured":"Sawanobori Y, Kitazawa Y, Ueta H, Matsuno K, Tokuda N. Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1+ dendritic cells, and epithelium-free areas containing Foxp3+ thymic regulatory T cells. Histochem Cell Biol. 2021, 156:133-46. 10.1007\/s00418-021-01993-y","journal-title":"Histochem Cell Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.01.045","article-title":"Cyclosporin A inhibits differentiation and activation of monocytic cells induced by 27-hydroxycholesterol","volume":"69","author":"Son Y","year":"2019","unstructured":"Son Y, Choi J, Kim B, et al.. Cyclosporin A inhibits differentiation and activation of monocytic cells induced by 27-hydroxycholesterol. Int Immunopharmacol. 2019, 69:358-67. 10.1016\/j.intimp.2019.01.045","journal-title":"Int Immunopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF00180033","article-title":"Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption","volume":"71","author":"Heering P","year":"1993","unstructured":"Heering P, Schadewaldt P, Bach D, Grabensee B. Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption. Clin Investig. 1993, 71:1010-5. 10.1007\/BF00180033","journal-title":"Clin Investig"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2020.0123","article-title":"The pattern of cyclosporine nephrotoxicity and urinary kidney injury molecule 1 in allogenic hematopoietic stem cell transplant patients","volume":"19","author":"Karimzadeh I","year":"2021","unstructured":"Karimzadeh I, Jafari M, Davani-Davari D, Ramzi M. The pattern of cyclosporine nephrotoxicity and urinary kidney injury molecule 1 in allogenic hematopoietic stem cell transplant patients. Exp Clin Transplant. 2021, 19:553-62. 10.6002\/ect.2020.0123","journal-title":"Exp Clin Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Ho\u0161kov\u00e1 L","year":"2017","unstructured":"Ho\u0161kov\u00e1 L, M\u00e1lek I, Kopkan L, Kautzner J. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension. Physiol Res. 2017, 66:167-80. 10.33549\/physiolres.933332","journal-title":"Physiol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.08.024","article-title":"Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: role of arterial baroreflexes and vasoreactivity","volume":"163","author":"Nasser SA","year":"2016","unstructured":"Nasser SA, Sabra R, Elmallah AI, El-Din MM, Khedr MM, El-Mas MM. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: role of arterial baroreflexes and vasoreactivity. Life Sci. 2016, 163:1-10. 10.1016\/j.lfs.2016.08.024","journal-title":"Life Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2018-0753","article-title":"Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system","volume":"97","author":"Bekpinar S","year":"2019","unstructured":"Bekpinar S, Karaca E, Yamako\u011flu S, et al.. Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system. Can J Physiol Pharmacol. 2019, 97:1115-23. 10.1139\/cjpp-2018-0753","journal-title":"Can J Physiol Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5115\/acb.18.192","article-title":"Cyclosporin A aggravates hydrogen peroxide-induced cell death in kidney proximal tubule epithelial cells","volume":"52","author":"Moon D","year":"2019","unstructured":"Moon D, Kim J. Cyclosporin A aggravates hydrogen peroxide-induced cell death in kidney proximal tubule epithelial cells. Anat Cell Biol. 2019, 52:312-23. 10.5115\/acb.18.192","journal-title":"Anat Cell Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2018.06.054","article-title":"Mechanism of cyclosporine A nephrotoxicity: oxidative stress, autophagy, and signalings","volume":"118","author":"Wu Q","year":"2018","unstructured":"Wu Q, Wang X, Nepovimova E, Wang Y, Yang H, Kuca K. Mechanism of cyclosporine A nephrotoxicity: oxidative stress, autophagy, and signalings. Food Chem Toxicol. 2018, 118:889-907. 10.1016\/j.fct.2018.06.054","journal-title":"Food Chem Toxicol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00417.2018","article-title":"Cyclophilin D knockout protects the mouse kidney against cyclosporin A-induced oxidative stress","volume":"317","author":"Klawitter J","year":"2019","unstructured":"Klawitter J, Klawitter J, Pennington A, et al.. Cyclophilin D knockout protects the mouse kidney against cyclosporin A-induced oxidative stress. Am J Physiol Renal Physiol. 2019, 317:F683-94. 10.1152\/ajprenal.00417.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2019.02.002","article-title":"Drug-induced hypertension: know the problem to know how to deal with it","volume":"115","author":"Masi S","year":"2019","unstructured":"Masi S, Uliana M, Gesi M, Taddei S, Virdis A. Drug-induced hypertension: know the problem to know how to deal with it. Vascul Pharmacol. 2019, 115:84-8. 10.1016\/j.vph.2019.02.002","journal-title":"Vascul Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.12.768","article-title":"Incidence and risk factors for acute and chronic kidney injury after adult cord blood transplantation","volume":"26","author":"Gutgarts V","year":"2020","unstructured":"Gutgarts V, Sathick IJ, Zheng J, et al.. Incidence and risk factors for acute and chronic kidney injury after adult cord blood transplantation. Biol Blood Marrow Transplant. 2020, 26:758-63. 10.1016\/j.bbmt.2019.12.768","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2015.10.052","article-title":"Race, calcineurin inhibitor exposure, and renal function after solid organ transplantation","volume":"47","author":"Yessayan L","year":"2015","unstructured":"Yessayan L, Shafiq A, Peterson E, Wells K, Hu Y, Williams LK, Lanfear D. Race, calcineurin inhibitor exposure, and renal function after solid organ transplantation. Transplant Proc. 2015, 47:2968-72. 10.1016\/j.transproceed.2015.10.052","journal-title":"Transplant Proc"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00455.x","article-title":"Renal dysfunction in allogeneic hematopoietic cell transplantation","volume":"62","author":"Parikh CR","year":"2002","unstructured":"Parikh CR, McSweeney PA, Korular D, et al.. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 2002, 62:566-73. 10.1046\/j.1523-1755.2002.00455.x","journal-title":"Kidney Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.569291","article-title":"Validation of early increase in complement activation marker sc5b-9 as a predictive biomarker for the development of thrombotic microangiopathy after stem cell transplantation","volume":"7","author":"Mez\u00f6 B","year":"2020","unstructured":"Mez\u00f6 B, Horv\u00e1th O, Sinkovits G, Veszeli N, Kriv\u00e1n G, Proh\u00e1szka Z. Validation of early increase in complement activation marker sc5b-9 as a predictive biomarker for the development of thrombotic microangiopathy after stem cell transplantation. Front Med (Lausanne). 2020, 7:569291. 10.3389\/fmed.2020.569291","journal-title":"Front Med (Lausanne)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001315","article-title":"New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT","volume":"4","author":"Elfeky R","year":"2020","unstructured":"Elfeky R, Lucchini G, Lum SH, et al.. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT. Blood Adv. 2020, 4:2418-29. 10.1182\/bloodadvances.2019001315","journal-title":"Blood Adv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels EA","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al.. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011, 306:1891-901. 10.1001\/jama.2011.1592","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2020.100283","article-title":"Post-renal transplant malignancies: opportunities for prevention and early screening","volume":"26","author":"Turshudzhyan A","year":"2021","unstructured":"Turshudzhyan A. Post-renal transplant malignancies: opportunities for prevention and early screening. Cancer Treat Res Commun. 2021, 26:100283. 10.1016\/j.ctarc.2020.100283","journal-title":"Cancer Treat Res Commun"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4108","article-title":"The association between immunosuppression and skin cancer in solid organ transplant recipients: a control-matched cohort study of 2,852 patients","volume":"31","author":"Gibson JA","year":"2021","unstructured":"Gibson JA, Cordaro A, Dobbs TD, et al.. The association between immunosuppression and skin cancer in solid organ transplant recipients: a control-matched cohort study of 2,852 patients. Eur J Dermatol. 2021, 31:712-21. 10.1684\/ejd.2021.4108","journal-title":"Eur J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett GL","year":"2017","unstructured":"Garrett GL, Blanc PD, Boscardin J, et al.. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol. 2017, 153:296-303. 10.1001\/jamadermatol.2016.4920","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113506-current-status-of-adverse-event-profile-of-cyclosporine-in-kidney-stem-cell-and-heart-transplantations-using-the-japanese-pharmacovigilance-database","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:34Z","timestamp":1707507574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113506-current-status-of-adverse-event-profile-of-cyclosporine-in-kidney-stem-cell-and-heart-transplantations-using-the-japanese-pharmacovigilance-database"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.29383","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,20]]}}}